Melbourne (Australia) and Liège (Belgium) – 15 October 2018. Telix Pharmaceuticals Limited announced that it has expanded its partnership with Advanced Nuclear Medicine Ingredients SA for the 68Ga-HBED-CC-PSMA-11 (68Ga-PSMA) cold kit. The 68Ga-PSMA kit is developed by ANMI and commercialized by Telix for the US market where it is marketed as illumetTM. The full media release can be accessed here.